Santa Clara, CA 11/11/08—Affymetrix has agreed to acquire Panomics, a provider of assay products, for $73 million in cash. Panomics offers products for low to mid-plex genetic, protein and cellular analysis applications that enable a direct assay approach that does not require nucleic acid extraction or amplification. “Panomics presented a great opportunity for Affymetrix to […]
West Chester, PA 11/11/08—Laboratory product distributor VWR International has signed a distribution agreement with Corning Life Sciences that will take effect in January 2009. Corning Life Sciences manufacturers microplates, laboratory glassware and plasticware for cell cultures and liquid handling, as well as filtration devices. “In a committed effort to provide our customers with structured choice […]
Sydney, Australia 10/14/08 and 10/30/08—Fluorotechnics, a manufacturer of fluorescence and electrophoresis consumables and tools, raised AUD$7.6 million ($4.9 million) in its IPO (see IBO 9/15/08). The company listed shares on the Australian Stock Exchange on October 31 at a price of AUD$1 ($0.68) per share for a market capitalization of nearly AUD$25 million ($16.9 million).
Waltham, MA 11/10/08—PerkinElmer has announced that it will refocus its business into two areas, Human Health and Environmental Health, beginning January 1, 2009. The Human Health business will include the company’s Genetic Screening, Bio-discovery and Medical Imaging operating units and will be led on an interim basis by company President and CEO Robert Friel. The […]
Carlsbad, CA 10/28/08; Norwalk, CT 10/28/08—On October 28, Invitrogen and Applied Biosystems’ shareholders voted in separate meetings to approve the companies’ merger agreement (see IBO 6/15/08). More than 98% of the each company’s shares voted were cast in favor of the transaction, according to the companies. The transaction is expected to close once the companies […]
Northbrook, IL 10/20/08—IDEX has acquired Semrock, a provider of optical filters for biotech and analytical instruments in the life sciences markets, for approximately $60 million in cash. Semrock generates annual revenues of approximately $21 million and is based in Rochester, New York. “Their expertise enables the continued expansion of our core capabilities in integrated fluidic […]
Carlsbad, CA 10/21/08—Invitrogen has announced the acquisition of VisiGen Biotechnologies, a developer of single-molecule sequencing technology, for $21 million in cash. VisiGen’s technology utilizes fluorescence resonance energy transfer technology and massively parallel arrays. Invitrogen Chairman and CEO Gregory Lucier commented that Invitrogen acquired VisiGen for its intellectual property and for the company’s strength in enzymology […]
Hopkinton, MA 10/29/07; Washington, DC 10/30/08—Caliper Life Sciences has agreed to sell its Pharmaceutical Development & Quality Analysis (PDQ) product line to SOTAX for approximately $13.8 million in cash and $2 million of assumed liabilities. The PDQ line consists of the TPW3 tablet processing workstation, the APW3 active ingredient processing workstation, the MultiDose G3 dissolution […]
Santa Clara, CA 10/22/08—Affymetrix has announced that its founder, Chairman and CEO Stephen P.A. Fodor, PhD, will step down at the end of the year. Replacing Dr. Fodor will be President Kevin M. King, who will become CEO and a member of the Board of Directors on January 1, 2009. Dr. Fodor will become full-time […]
Cleveland, OH 10/1/08—Parker Hannifin has purchased Hargraves Technology. Hargraves designs and manufactures miniature liquid and pneumatic diaphragm pumps, control valves and system solutions for medical devices, life science analytical instruments, as well as diagnostics, gas detection and printing systems. Based in Mooresville, North Carolina, Hargraves had 2007 sales of $14 million. Parker Hannifin will form […]
Pay Invoice
Latest Blogs
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
-
Single Use Leads Bioreactor Market Growth
December 30, 2025 6:04 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
